Impact of macrolide treatment on long-term mortality in patients admitted to the ICU due to CAP: a targeted maximum likelihood estimation and survival analysis

Impact of macrolide treatment on long-term mortality in patients admitted to the ICU due to CAP: a targeted maximum likelihood estimation and survival analysis

Abstract Introduction Patients with community-acquired pneumonia (CAP) admitted to the intensive care unit (ICU) have high mortality rates during the acute infection and up to ten years thereafter. Recommendations from international CAP guidelines include macrolide-based treatment. However, there is...

Full description

Bibliographic Details
Main Authors: Luis Felipe Reyes, Esteban Garcia, Elsa D. Ibáñez-Prada, Cristian C. Serrano-Mayorga, Yuli V. Fuentes, Alejandro Rodríguez, Gerard Moreno, Alirio Bastidas, Josep Gómez, Angélica Gonzalez, Christopher R. Frei, Leo Anthony Celi, Ignacio Martin-Loeches, Grant Waterer
Format: Article
Language:English
Published: BMC 2023-05-01
Series:Critical Care
Subjects:
Community-acquired pneumonia
Macrolide
Mortality
β-lactam
Online Access:https://doi.org/10.1186/s13054-023-04466-x

Internet

https://doi.org/10.1186/s13054-023-04466-x

Similar Items